Literature DB >> 23107233

Pulmonary mucormycosis: what is the best strategy for therapy?

Juan F Fernandez1, Diego J Maselli, Tamara Simpson, Marcos I Restrepo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23107233      PMCID： PMC4066629          DOI： 10.4187/respcare.02106

Source DB:  PubMed          Journal:  Respir Care        ISSN： 0020-1324            Impact factor:   2.258


× No keyword cloud information.
  13 in total

Review 1.  Hyperbaric oxygen as an adjunctive treatment for zygomycosis.

Authors:  B V John; G Chamilos; D P Kontoyiannis
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

2.  Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital.

Authors:  V Saegeman; J Maertens; N Ectors; W Meersseman; K Lagrou
Journal:  Med Mycol       Date:  2010-03       Impact factor: 4.076

Review 3.  Pulmonary mucormycosis: the last 30 years.

Authors:  F Y Lee; S B Mossad; K A Adal
Journal:  Arch Intern Med       Date:  1999-06-28

Review 4.  Pulmonary fungal infections.

Authors:  Jeannina A Smith; Carol A Kauffman
Journal:  Respirology       Date:  2012-08       Impact factor: 6.424

5.  Contraindications and safety of transbronchial lung biopsy via flexible bronchoscopy. A survey of pulmonologists and review of the literature.

Authors:  Momen M Wahidi; Ana T Rocha; John W Hollingsworth; Joseph A Govert; David Feller-Kopman; Armin Ernst
Journal:  Respiration       Date:  2005 May-Jun       Impact factor: 3.580

6.  Recent advances in the treatment of mucormycosis.

Authors:  Brad Spellberg; Ashraf S Ibrahim
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

7.  Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies.

Authors:  Lorenz Grigull; Andreas Beilken; Hansjoerg Schmid; P Kirschner; Karl-Walter Sykora; Christin Linderkamp; Frank Donnerstag; Lilia Goudeva; Hans-Gert Heuft; Karl Welte
Journal:  Support Care Cancer       Date:  2006-02-16       Impact factor: 3.603

8.  Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.

Authors:  Georgios Chamilos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

Review 9.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

10.  Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

Authors:  Caitlin Reed; Richard Bryant; Ashraf S Ibrahim; John Edwards; Scott G Filler; Robert Goldberg; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079
View more
  10 in total

Review 1.  Pulmonary Mucormycosis Over 130 Years: A Case Report and Literature Review.

Authors:  Hasan S Yamin; Amro Y Alastal; Izzedin Bakri
Journal:  Turk Thorac J       Date:  2017-01-01

2.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

3.  Refractory bronchovascular pleuropulmonary mucormycosis: Case report and difficulties in management.

Authors:  M Manjunath; Deepak Prajapat; Rahul Kumar Sharma; Deepak Talwar
Journal:  Lung India       Date:  2018 Jan-Feb

4.  Characteristics of pulmonary mucormycosis and the experiences of surgical resection.

Authors:  Weipeng Shao; Jun Zhang; Shanwu Ma; Hongxiang Feng; Zhenrong Zhang; Chaoyang Liang; Deruo Liu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

5.  A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.

Authors:  Daniela Pasero; Silvana Sanna; Corrado Liperi; Davide Piredda; Gian Pietro Branca; Lorenzo Casadio; Raffaella Simeo; Alice Buselli; Davide Rizzo; Francesco Bussu; Salvatore Rubino; Pierpaolo Terragni
Journal:  Infection       Date:  2020-12-17       Impact factor: 3.553

Review 6.  Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India.

Authors:  Deganta Ghosh; Sagardeep Dey; Himanko Chakraborty; Sneha Mukherjee; Ankita Halder; Akash Sarkar; Pallab Chakraborty; Rajdeep Ghosh; Joy Sarkar
Journal:  Clin Epidemiol Glob Health       Date:  2022-03-19

7.  Pulmonary Mucormycosis in a Patient with Chronic Rejection of Kidney Transplant: A Case Report.

Authors:  Mahshid Talebi-Taher; Seyedeh Nina Alavi Niakou; Seied Ali Javad-Mousavi; Mohammad Vaziri; Aida Iranpour; Maryam Dehghani
Journal:  Tanaffos       Date:  2015

8.  Mucormycosis causing pulmonary artery aneurysm.

Authors:  Lakshman Ramachandran; Sandeep Dewan; Vishal Kumar; Bhushan Wankhade
Journal:  Respir Med Case Rep       Date:  2015-07-31

9.  Rare complication of bronchoesophageal fistula due to pulmonary mucormycosis after induction chemotherapy for acute myeloid leukemia: a case report.

Authors:  Jun-Hyung Lee; Jin-Soo Hyun; Da-Yeong Kang; Hee-Jeong Lee; Sang-Gon Park
Journal:  J Med Case Rep       Date:  2016-07-16

Review 10.  Pulmonary mucormycosis in systemic lupus erythematosus: successful management of a case along with review of literature.

Authors:  Rajat Kharbanda; Anurag Mehndiratta; Rudrarpan Chatterjee; Rungmei S K Marak; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2021-10-04       Impact factor: 3.650
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.